News
News from the BioCity Campus

Virtual Finance Day 2020 - "Corona as a turbo for biotechnology?"

Take a look at the current biotechnology scene together on October 21.10.2020, 14.00 from XNUMX p.m. What does Corona mean for companies, investors and start-ups? How does the current situation affect corporate financing?

Unfortunately, since the current situation does not allow face-to-face events, the popular format “Finance Day” 2020, which has been part of the leading trade fair analytica (Messe München) for the last 14 years, will be made possible in a digital framework at short notice. You are cordially invited to participate in the live stream on October 21.10.20, 14 from XNUMX p.m. And that with really outstanding participants and topics!

For 14 years now and also at Finance Day 2020, the focus has been on growth financing challenges and solutions for life sciences companies. Participate directly in the discussion with the experts via the chat function!

More information and link to the live stream


Programme

14:00 - 14:05

Greeting: Mathias Renz, GoingPublic Media AG & Karin Hofelich, Publishing Director Platform Life Sciences

14:05 - 14:45

"Close-up": The BioNTech Story - From German start-up to stock market star
How well is Germany positioned for the global market?

dr Sierk Pötting, CFO & COO, BioNTech SE and Michael Motschmann, General Partner of MIG AG
in conversation with Mathias Renz

14:45 - 15:00

“View from Abroad”: Fundraising Lessons Learned
Marc Filerman, Program CEO German Accelerator Life Sciences

15:00 - 16:15

"Wide angle": Financing trends and financing models - everything new in times of Corona?
Moderator: Dr. Hubert Birner, Managing Partner of TVM Life Science

For you in the studio as experts for Early Stage & Venture Capital:

  • dr Viola Bronsema, Managing Director BIO Germany
  • Andreas Huber, Senior Investment Manager Bayern Kapital
  • dr Holger N. Reithinger, Partner Forbion Capital Partners

For you in the studio as experts for Growth financing and IPO:

  • Sebastian Grabert, Germany Representative EURONEXT
  • Markus Gross, Partner FAS
  • Enno Spillner, CFO of Evotec SE

16:15 - 17:00

"In the Spotlight": Corona - Turbo for the unicorns of tomorrow?
Moderator: Dr. Georg Kääb, Managing Director of the Bavarian Biotech Cluster
in conversation with

  • Frans Matthis Pleie, director Bryan Garnier
  • Marc L. Holtorf, Partner Pinsent Mason
  • dr Marion Jung, CEO of ChromoTek
  • dr Hella Kohlhof, CSO Immunic Therapeutics

Closing words and outlook for 2021


Source: Press release Platform Life Sciences from 16.10.2020


previous news

CO.DON AG: First Spherox transplantation successfully carried out in Switzerland

At the Inselspital Bern, one of the leading orthopedic centers in Switzerland, the first patient was treated with the autologous cartilage cell transplant Spherox. Last week Prof. Dr. medical dr phil. of course Frank M. Klenke, Deputy Clinic Director and Team Leader for Knee and Sports Orthopedics at the University Clinic for Orthopedic Surgery and Traumatology at Inselspital Bern, the drug.

NextNews

Marketingclub Leipzig is looking for prizewinners 2020

For the 23rd time, the Marketing Club Leipzig is looking for winners for the Marketing Prize. The award is given in four categories and is advertised until the end of November. Last year, the company Vita34 was happy about the main prize.